323 related articles for article (PubMed ID: 19060589)
1. Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Am J Clin Oncol; 2008 Dec; 31(6):567-72. PubMed ID: 19060589
[TBL] [Abstract][Full Text] [Related]
2. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1131-9. PubMed ID: 17446000
[TBL] [Abstract][Full Text] [Related]
3. Hypopituitarism after radiotherapy for extracranial head and neck cancers.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Head Neck; 2008 Sep; 30(9):1182-92. PubMed ID: 18446838
[TBL] [Abstract][Full Text] [Related]
4. Ototoxicity after radiotherapy for head and neck tumors.
Bhandare N; Antonelli PJ; Morris CG; Malayapa RS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):469-79. PubMed ID: 17236969
[TBL] [Abstract][Full Text] [Related]
5. Endocrine complications after radiotherapy for tumors of the head and neck.
Samaan NA; Schultz PN; Yang KP; Vassilopoulou-Sellin R; Maor MH; Cangir A; Goepfert H
J Lab Clin Med; 1987 Mar; 109(3):364-72. PubMed ID: 3819573
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction in patients treated with radiotherapy for neck.
Koc M; Capoglu I
Am J Clin Oncol; 2009 Apr; 32(2):150-3. PubMed ID: 19307948
[TBL] [Abstract][Full Text] [Related]
7. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid function after external irradiation of the neck in patients with Hodgkin's disease--long-term observation].
Ziora K; Bubała H; Głowacki J; Sońta-Jakimczyk D; Legaszewski T; Zajecki W
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):261-7. PubMed ID: 17239303
[TBL] [Abstract][Full Text] [Related]
9. Preventing radiation retinopathy with hyperfractionation.
Monroe AT; Bhandare N; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):856-64. PubMed ID: 15708266
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced hypopituitarism.
Fernandez A; Brada M; Zabuliene L; Karavitaki N; Wass JA
Endocr Relat Cancer; 2009 Sep; 16(3):733-72. PubMed ID: 19498038
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol].
Moryl-Bujakowska A; Balwierz W; Sztefko K
Przegl Lek; 2004; 61 Suppl 2():81-4. PubMed ID: 15686053
[TBL] [Abstract][Full Text] [Related]
13. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients.
Alterio D; Jereczek-Fossa BA; Franchi B; D'Onofrio A; Piazzi V; Rondi E; Ciocca M; Gibelli B; Grosso E; Tradati N; Mariani L; Boboc GI; Orecchia R
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):144-50. PubMed ID: 17084554
[TBL] [Abstract][Full Text] [Related]
14. Adrenal function testing in pediatric cancer survivors.
Patterson BC; Truxillo L; Wasilewski-Masker K; Mertens AC; Meacham LR
Pediatr Blood Cancer; 2009 Dec; 53(7):1302-7. PubMed ID: 19637328
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine sequela of radiation treatment of extracranial head and neck tumors].
Czernichow P; Cachin O; Rappaport R; Flamant F; Sarrazin D; Schweisguth O
Arch Fr Pediatr; 1977; 34(7 Suppl):CLIV-CLXIV. PubMed ID: 412481
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
17. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).
Bölling T; Geisenheiser A; Pape H; Martini C; Rübe C; Timmermann B; Fischedick K; Kortmann RD; Gerss J; Koch R; Willich N
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e787-91. PubMed ID: 21167655
[TBL] [Abstract][Full Text] [Related]
18. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
[TBL] [Abstract][Full Text] [Related]
19. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency.
Snyers A; Janssens GO; Twickler MB; Hermus AR; Takes RP; Kappelle AC; Merkx MA; Dirix P; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1343-51. PubMed ID: 18963535
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
